China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
China Medical System Dividend Announcement
• China Medical System announced a semi annually dividend of HK$0.16 per ordinary share which will be made payable on 2024-09-09. Ex dividend date: 2024-08-29
• China Medical System annual dividend for 2024 was HK$0.25
• China Medical System annual dividend for 2023 was HK$0.62
• China Medical System's trailing twelve-month (TTM) dividend yield is 3.39%
• China Medical System's payout ratio for the trailing twelve months (TTM) is 69.08%
• China Medical System's dividend growth over the last five years (2018-2023) was 12.03% year
• China Medical System's dividend growth over the last ten years (2013-2023) was 17.29% year
China Medical System Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-29 | HK$0.16 | semi annually | 2024-09-09 |
2024-05-13 | HK$0.09 | semi annually | 2024-05-23 |
2023-09-11 | HK$0.34 | semi annually | 2023-09-20 |
2023-05-03 | HK$0.27 | semi annually | 2023-05-12 |
2022-09-05 | HK$0.34 | semi annually | 2022-09-15 |
2022-04-26 | HK$0.28 | semi annually | 2022-05-06 |
2021-09-06 | HK$0.32 | semi annually | 2021-09-15 |
2021-04-29 | HK$0.24 | semi annually | 2021-05-10 |
2020-08-26 | HK$0.23 | semi annually | 2020-09-04 |
2020-06-08 | HK$0.14 | semi annually | 2020-06-17 |
2019-08-30 | HK$0.21 | semi annually | 2019-09-10 |
2019-04-29 | HK$0.17 | semi annually | 2019-05-09 |
2018-09-10 | HK$0.18 | semi annually | 2018-09-19 |
2018-04-30 | HK$0.17 | semi annually | 2018-05-10 |
2017-09-04 | HK$0.15 | semi annually | 2017-09-13 |
2017-04-28 | HK$0.13 | semi annually | 2017-05-12 |
2016-09-02 | HK$0.12 | semi annually | |
2016-04-26 | HK$0.10 | semi annually | |
2015-08-27 | HK$0.10 | semi annually | |
2015-05-05 | HK$0.09 | semi annually | |
2014-08-28 | HK$0.09 | semi annually | |
2014-05-05 | HK$0.07 | semi annually | |
2013-08-19 | HK$0.07 | semi annually | |
2013-04-26 | HK$0.06 | semi annually |
China Medical System Dividend per year
China Medical System Dividend growth
China Medical System Dividend Yield
China Medical System current trailing twelve-month (TTM) dividend yield is 3.39%. Interested in purchasing China Medical System stock? Use our calculator to estimate your expected dividend yield:
China Medical System Financial Ratios
China Medical System Dividend FAQ
Other factors to consider when evaluating China Medical System as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Medical System stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Medical System's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Medical System publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Medical System distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Medical System are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Medical System sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Medical System distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Medical System declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Medical System's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Medical System's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.